Philips will pay more than $62 million to settle charges that it violated the Foreign Corrupt Practices Act (FCPA) when selling medical diagnostic equipment in China, the U.S. Securities and Exchange Commission said on Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,